Micardis Plus Adverse Reactions

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

The information highlighted (if any) are the most recent updates for this brand.

Full Prescribing Info

Adverse Reactions

Summary of the safety profile: The overall incidence of adverse events reported with Telmisartan + HCTZ (Micardis Plus) was comparable to those reported with telmisartan alone in randomised controlled trials involving 1471 patients receiving telmisartan plus hydrochlorothiazide (835) or telmisartan alone (636). There was no dose-relationship to undesirable effects and there was no correlation with gender, age or race of the patients.
Tabulated summary of adverse reactions: The following adverse reactions derived from the use of telmisartan/hydrochlorothiazide combination or the use of monocomponents telmisartan or hydrochlorothiazide in clinical trials or from post-marketing experience are shown in the table as follows classified by MedDRA System organ class and MedDRA Preferred Terms. (See Table A and B.)

Click on icon to see table/diagram/image

View ADR Reporting Link

Micardis Plus Adverse Reactions

telmisartan + hydrochlorothiazide

Manufacturer:

Boehringer Ingelheim

Distributor:

Metro Drug